CTNNBIP1 downregulation is associated with tumor grade and viral infections in gastric adenocarcinoma.


Journal

Journal of cellular physiology
ISSN: 1097-4652
Titre abrégé: J Cell Physiol
Pays: United States
ID NLM: 0050222

Informations de publication

Date de publication:
03 2019
Historique:
received: 31 01 2018
accepted: 29 06 2018
pubmed: 5 8 2018
medline: 21 1 2020
entrez: 5 8 2018
Statut: ppublish

Résumé

Gastric cancer is a life-threatening disease; resulting from interaction among genetic, epigenetic, and environmental factors. Aberrant dysregulation and methylation changes in Wnt/β-catenin signaling downstream elements are a prevalent phenomenon encountered in gastric tumorigenesis. Also, viral infections play a role in gastric cancer development. CTNNBIP1 (β-catenin interacting protein 1) gene is an antagonist of Wnt signaling which binds to the β-catenin molecules. The CTNNBIP1 function as tumor suppressor gene or oncogene in different types of cancer is controversial. Moreover, its function and regulatory mechanisms in gastric cancer progression is unknown. In the present study, we examined CTNNBIP1 gene expression, the methylation status of the regulatory region of the gene, and their association with Epstein-Barr virus (EBV), and cytomegalovirus (CMV) and Helicobacter pylori infections in human gastric adenocarcinoma tissues in comparison with their adjacent nontumoral tissues. Our data revealed a significant downregulation of CTNNBIP1 in gastric tumors. Female patients showed lower level of CTNNBIP1 than males (p < 0.05). Also, decreased expression of CTNNBIP1 was markedly associated with well-differentiated tumor grades (p < 0.05). No methylation change was observed between tumoral and nontumoral tissues. Additionally, CTNNBIP1 down regulation was significantly associated with CMV infection (p < 0.05). In the absence of EBV infection, lower expression of CTNNBIP1 was observed. There was no association between H. pylori infection and CTNNBIP1 expression. Our findings revealed the tumor suppressor role for CTNNBIP1 in gastric adenocarcinoma. Interestingly, EBV and CMV infections modulate CTNNBIP1 expression.

Identifiants

pubmed: 30076728
doi: 10.1002/jcp.27106
doi:

Substances chimiques

Adaptor Proteins, Signal Transducing 0
CTNNB1 protein, human 0
CTNNBIP1 protein, human 0
beta Catenin 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2895-2904

Informations de copyright

© 2018 Wiley Periodicals, Inc.

Auteurs

Mohadeseh Kosari-Monfared (M)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

Novin Nikbakhsh (N)

Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Sadegh Fattahi (S)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Molecular Biology Laboratory, North Research Center of Pasteur Institute, Amol, Iran.

Elham Ghadami (E)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

Mohammad Ranaei (M)

Department of Pathology, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

Hassan Taheri (H)

Department of Internal Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

Fatemeh Amjadi-Moheb (F)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

Gholam A Godazandeh (GA)

Department of Surgery, Imam Hospital, Mazandaran University of Medical Sciences, Sari, Iran.

Shahryar Shafaei (S)

Department of Pathology, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran.

Maryam Pilehchian-Langroudi (M)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.

Ali Akbar Samadani (AA)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Gastrointestinal and Liver Diseases Research Center (GLDRC), Guilan University of Medical Sciences, Rasht, Iran.

Haleh Akhavan-Niaki (H)

Cellular and Molecular Biology Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.
Department of Genetics, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran.
Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH